Document is current
Any future updates will be listed below
-
Authors
Chen, Tsai-Wen https://orcid.org/0000-0001-6782-3819
Huang, Xian-Bin
Plutkis, Sarah E.
Holland, Katie L.
Lavis, Luke D.
Lin, Bei-Jung
- License Information
-
More Information
Article History
Received: 20 December 2023
Accepted: 1 April 2025
First Online: 19 May 2025
Competing interests
: US patents 9,933,417 and 11,091,643 and US patent application US 2021/0085805, describing azetidine-containing fluorophores and variant compositions (with L.D.L. as an inventor), are assigned to the HHMI. US patent 11,385,236, describing chemigenetic voltage indicators (with L.D.L. as an inventor), is also assigned to the HHMI. L.D.L. serves on the advisory board of Cell Chemical Biology and is a founder and shareholder of Eikon Therapeutics. The other authors declare no competing interests.
